Experimental Pathology Laboratory Shared Resource
Experimental Pathology Laboratory Shared Resource
批准号:
9772006
负责人:
Richard Brott Halberg
金额:
$0.33万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAnimal ModelBiological AssayBiological MarkersCancer BiologyCancer Center Support GrantCancer EtiologyChargeComprehensive Cancer CenterConsultConsultationsCustomDataDevelopmentExperimental PathologyFundingHematoxylin and Eosin Staining MethodHistologyHistopathologyHourImmunofluorescence ImmunologicImmunohistochemistryInstitutesLaboratoriesMalignant NeoplasmsMethodsMissionMolecular AnalysisPathologistPathologyPreparationPrevention therapyPriceProceduresProcessProteinsProtocols documentationPublishingResearchResearch InfrastructureResearch PersonnelResearch SupportResource SharingSamplingSeminalServicesSlideSpecimenStainsStandardizationSurveysTissuesTrainingTranslational ResearchValidationWalkingWorkanticancer researchcostdata acquisitionexperiencefluorescence microscopehistotechnologyhuman modelimaging platforminterestliquid crystal polymermembermicroscopic imagingmolecular phenotypeneoplasticoperationprogramstherapeutic targetvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
The mission of the Experimental Pathology Laboratory (EPL) is to provide a comprehensive array of
histopathology services and expertise that enable UWCCC members to fully exploit the power of animal
models of human cancer to reveal mechanisms that contribute to cancer development, progression, and
responsiveness to therapies. EPL staff have extensive expertise in histology, histopathology, and cancer
biology and together possess nearly 100 years of experience in cancer research. EPL has served a total of 99
UWCCC members during the current CCSG funding cycle, and between 43 and 58 unique members per year
used EPL services during this interval. Both the number of members using EPL and the volume of services
provided have increased since the CCSG was last reviewed and data from a 2016 survey of members indicate
use will continue to increase. EPL prioritizes the following three aims: Aim 1 is to provide essential histology
services to UWCCC members. Our members utilize a wide variety of animal models to address important
questions pertaining to cancer etiology, prevention, and therapy. The EPL supports this research by providing
essential histology services and expertise. Tissue specimens collected by UWCCC investigators are
transported to the EPL where they are processed, embedded, sectioned, and stained according to the
requirements of the investigator and our Standardized Operating Procedures. EPL offers common staining
protocols, for example hematoxylin and eosin (H&E), and can perform virtually any special stain. Expert
pathology consultation is provided by Dr. Ruth Sullivan, a board certified veterinary pathologist and EPL staff
member. Aim 2 is to facilitate the molecular analyses of normal and neoplastic tissues. UWCCC members
frequently evaluate expression, function, or localization of specific proteins as biomarkers or therapeutic
targets. Upon request of a member, the EPL will develop and implement a custom immunohistochemistry
(IHC) or immunofluorescence (IF) protocol that is specific to a protein of interest. Our members view this
service as invaluable and over 70 unique IHC or IF protocols have been developed, optimized, and validated
by EPL during the current CCSG funding cycle. Aim 3 is to provide histopathology expertise to UWCCC
members and researchers. EPL staff members are available for walk-in consultation on sample preparation
and handling or on operation of our Nikon fluorescence microscope for image acquisition. Dr. Sullivan provides
monthly slide reviews and tutorials to UWCCC researchers free of charge. In addition, Dr. Sullivan is available
for general pathology consults. Support from the CCSG allows us to provide UWCCC members with priority
access to high quality histopathology services at costs below those of commercial laboratories as well as to
provide expert consultative support at no cost to members.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Features of the early adenoma and adjacent colon that drive progression: the role of mutation burden in normal tissue, senescent cells, and tumor clonal architecture
-
批准号:10707105
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2022
-
负责人:Richard Brott Halberg
-
依托单位:
Features of the early adenoma and adjacent colon that drive progression: the role of mutation burden in normal tissue, senescent cells, and tumor clonal architecture
-
批准号:10519075
-
项目类别:
-
资助金额:$39.03万
-
财政年份:2022
-
负责人:Richard Brott Halberg
-
依托单位:
Molecular Differences Predicting Tumor Progression in Colorectal Cancer (PQ #14)
-
批准号:8538333
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2012
-
负责人:Richard Brott Halberg
-
依托单位:
Molecular Differences Predicting Tumor Progression in Colorectal Cancer (PQ #14)
-
批准号:8384609
-
项目类别:
-
资助金额:$19.64万
-
财政年份:2012
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:7766296
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:7652563
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:8225175
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:8446525
-
项目类别:
-
资助金额:$28.1万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
Polyclonal Intestinal Tumors: Formation, Progression, and Significance
-
批准号:8033178
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2009
-
负责人:Richard Brott Halberg
-
依托单位:
MODIFIERS OF INTESTINAL NEOPLASIA IN MICE
-
批准号:2896499
-
项目类别:
-
资助金额:$4.17万
-
财政年份:1999
-
负责人:Richard Brott Halberg
-
依托单位:
MODIFIERS OF INTESTINAL NEOPLASIA IN MICE
-
批准号:2642965
-
项目类别:
-
资助金额:$3.28万
-
财政年份:1998
-
负责人:Richard Brott Halberg
-
依托单位:
Experimental Pathology Laboratory Shared Resource
-
批准号:9923031
-
项目类别:
-
资助金额:$4.99万
-
财政年份:--
-
负责人:Richard Brott Halberg
-
依托单位:
海外基金